Ubiquitin System: The Next Class of Drug Targets?
A Complex Role in Cellular Process & Growing Tool Set to Elucidate It
Bispecific Antibodies Close in on Cancer
Plotting Molecular Pincer Movements, Denying Cancer Room to Maneuver
Resolving Nonspecific Binding, Regeneration and Other Problems
Researchers Turn to Cloud Computing as Genomic Sequencing Data Threatens to Overwhelm Traditional IT Systems
Exempting Generic Drug Makers from Lawsuits
The Supreme Court recently ruled that generic drug makers cannot be sued on the grounds of adverse side effects if their product warning labels are the same as those from the brand-name manufacturers. The court overruled a multimillion dollar jury award to a woman in New Hampshire who was severely disfigured after taking a generic anti-inflammatory. In effect, the Supreme Court said the federal law trumps state law.